Cargando…
CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk
Immunosuppressive cytotoxic T lymphocyte associated antigen-4 immunoglobulin fusion proteins (CTLA4-Ig) block the CD28:CD80/86 costimulatory pathway. On a cellular level, CTLA4-Ig is understood to dampen T cell responses. As a mechanism, CTLA4-Ig has been reported to affect dendritic cell (DC) funct...
Autores principales: | Mayer, Edda, Hölzl, Markus, Ahmadi, Sarah, Dillinger, Barbara, Pilat, Nina, Fuchs, Dietmar, Wekerle, Thomas, Heitger, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629566/ https://www.ncbi.nlm.nih.gov/pubmed/23434857 http://dx.doi.org/10.1016/j.intimp.2013.02.007 |
Ejemplares similares
-
CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro
por: Pilat, Nina, et al.
Publicado: (2018) -
Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimen
por: Unger, Lukas W., et al.
Publicado: (2022) -
Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023) -
S43. Dendritic cell vaccination combined with CTLA4 blockade
por: Thielemans, K, et al.
Publicado: (2014) -
CTLA-4–Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice
por: Fallarino, Francesca, et al.
Publicado: (2004)